Manufacturing moonshot: How Pfizer makes its millions of Covid-19 vaccine doses
When the coronavirus pandemic began, the challenge for Pfizer and BioNTech wasn't just developing its Covid-19 vaccine -- it also had to make it, and by the hundreds of millions.
![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v1s1zwYQXsR8Y9-VOZ5UpZP8NU6sRdQ_gNufZDm5fmg1TVtoPOSOiyo6rvW55y1gYOlGcIP6X_cvfMwNJUDzpMJvUsTquhyypX2Lf8V8jdumxus9qvlay3MEqldYaI5w=s0-d)